The antitumor polypeptide, macromomycin (MCR) produced by Streptomyces macromomyceticus, was purified by ammonium sulfate precipitation, ultrafiltration and chromatographic techniques using Amberlite IRA-410, DEAE Sephadex A-25 (Cl-and OH-type) and Sephadex G-50. Purified MCR was obtained as a white powder by lyophilization.
The antitumor polypeptide, macromomycin (MCR) produced by Streptomyces macromomyceticus, was purified by ammonium sulfate precipitation, ultrafiltration and chromatographic techniques using Amberlite IRA-410, DEAE Sephadex A-25 (Cl-and OH-type) and Sephadex G-50. Purified MCR was obtained as a white powder by lyophilization.
MCR, thus purified, exhibited a single peak on Sephadex G-50 chromatography with no detectable contaminant by ultracentrifugation and polyacrylamide gel electrophoresis. MCR is an acidic polypeptide having an isoelectric point of pH 5.4. It contains no arginine and methionine.
The molecular weight was 11,700, 12,500 and 11,400 by amino acid composition, gel filtration and analytical ultracentrifugation, respectively.
MCR is labile as a lyophilized powder but is successfully stabilized by the addition of maltose.
Macromomycin (MCR) discovered by CHIMURA et a1.1) in 1968 was reported to be a polypeptide antitumor antibiotic produced by Streptomyces macromomyceticus and to prolong the lifespan of mice bearing L1210 leukemia and EHRLICH carcinoma. LIPPMAN et al. 2) reported that it inhibits L1210 leukemia, P388 leukemia, B16 melanoma and LEWIS lung carcinoma. According to KUNIMOTO et al.3, 4) , MCR binds to mammalian cell surfaces and causes inhibition of DNA synthesis. The study of LIPPMAN et al.u suggests that it is effective in increasing immunity to tumors.
Though macromomycin has interesting biological activities, it is unstable. Consequently it was necessary to study its physicochemical characters in detail in order to find a method for stabilizing this antibiotic. In this paper, we report further observations on characteristics of MCR and methods to obtain stable MCR powder.
Methods and Materials
Assay of MCR The cylinder agar plate method using Micrococcus flavus reported by CHIMURA et al .1) was employed. M. flavus was cultured at 33°C for 48 hours in a medium containing 2.0 % glucose, 1.0 % meat extract, 1.0 % peptone, and 0.3 % sodium chloride (pH 7.0). The agar medium contained 0.1 % glucose, 0.6 % peptone, 0.4 % casamino acid, 0.15 % meat extract, 0 .3 % yeast extract and 1.5 % agar; the pH was adjusted to 7.0.
Production of MCR S. macromomyceticus was cultured at 28°C for about 90 hours with aeration and agitation . The medium contained 1.0 % glucose, 1.0 0 soluble starch, 1.5 % soy bean meal, 0.1 % K2HPO4 , 0.1 °o MgSO4.7H2O, 0.3 % NaCl, 0.0007 % CuSO4.5H2O, 0.0001 % FeSO4.7H2O, 0.0008 % MnCl2•4H2O and 0.0002 % ZnSO4.7H2O at pH 7.2. In jar fermentations 0.05 % Disfoam CC-118 was added.
Purification of MCR Dicalite 4159 was added to the culture broth as filter aid and the broth filtered using a filter press. Dicalite 4159 was purchased from Dicalite Orient Co., Ltd. The filtrate was salted out by saturation with ammonium sulfate. MCR was purified by sequential use of Amberlite IRA-410 (Cl-type) chromatography, ultrafiltration, DEAE Sephadex A-25 (Cl-type) chromatography, Sephadex G-50 (fine) chromatography, DEAE Sephadex A-25 (OH-type) chromatography and Sephadex G-50 (fine) chromatography. Purified MCR was lyophilized and stored.
Homogeneity of MCR Analysis by ultracentrifugation was carried out on a solution containing 8 mg MCR/m1 by the sedimentation velocity method6) at 72,000 rpm for 90 minutes using a Hitachi Analytical Ultracentrifuge type 282.
Analytical polyacrylamide gel electrophoresis was done following the ORSTEIN-DAVIS system7,8). The gel type was pH 9.4, the concentration of the acrylamide monomer was 15 and the buffer solution was tris-glycine at pH 8.3. Polyacrylamide gel was made in a glass tube (5 mm of diameter, 60 mm of length). A sample of MCR was placed on the top of the gel with 1 M sucrose solution. Initially, a current of 3 mA per tube was applied, and then the current was increased to 5 mA per tube when the sample entered the gel. Exposure of MCR to light was carefully avoided during the treatment to avoid destruction. After electrophoresis for about 40 minutes, the gel was stained with amino black 1013 for 1 hour and the excess dye was rinsed away with a 7 % solution of acetic acid.
Determination of Isoelectric Point of MCR9) The isoelectric point of MCR was determined by electrofocusing with an LKB Ampholine 8101 using a carrier ampholyte with a pH range of 5 to 8. Seven mg of MCR was applied with an initial voltage of 300 V. After 12.5 hours, the voltage was increased to 700 V. Electrofocusing continued for 17.5 hours and then the carrier ampholyte in the focusing column was fractionated and the MCR in each fraction was determined by measuring the UV-absorption and the microbial activity.
Amino Acid Analysis of MCR The amino acid composition was analyzed using a Hitachi Amino Acid Analyzer KLA-5. MCR was hydrolyzed at 110°C for 22 hours in 6 N HCl or 4 N Ba(OH)2. Cysteine and methionine were analyzed by the method of performic acid oxidation. To ensure analysis of representative hydrolysates, various conditions for the hydrolysis of MCR were examined. Accordingly MCR was hydrolyzed in 3 N or 6 N HCl for 3, 6, 12, 22, 48 and 72 hours.
Estimation of Molecular Weight of MCR A Sephadex G-50 column (15 mm x 900 mm) was treated with 0.1 M phosphate buffer at pH 7.0 containing 0.1 M KCl10). Purified MCR was chromatographed with four different reference compounds. Three-ml fractions were collected at a flow rate of 35 ml/hour. The reference compounds, blue dextran 2000, human albumin (M.W. 45,000), chymotrypsinogen A (M.W. 25,000), and cytochrome C (M.W. 12,500) were purchased from Boehringer Mannheim Gmbh.
Analytical ultracentrifugation of a solution of MCR containing 0.4 mg/ml was carried out at 20,000 rpm for 16.5 hours by the sedimentation equilibrium method. Results were recorded by an ultraviolet absorption system. Acute Toxicity of MCR MCR was dissolved in 0.9 % NaCl solution and given to mice intravenously, intraperitoneally and orally. After administration, the mice were observed for two weeks.
Stability of MCR Compounds were screened for ability to stabilize MCR by the following method:
XXIX NO. 4 An aqueous solution of MCR and an aqueous solution of the compounds to be tested, selected from saccharides, amino acids, organic acids, inorganic salts and chelating agents, were mixed and adjusted to pH 5.0 to 7.5. Two ml of each resulting solution were placed in a vial of 10 ml volume and lyophilized with heating below 50°C. The vial was sealed and kept at 65°C for 55 hours.
The stability of a lyophilized powder containing 2 mg of MCR and 78 mg of maltose was examined. After lyophilization, the vials were sealed and stored at 35°, 45° and 50°C for 3, 6, 9, 12 and 15 days in the dark. The activity immediately after lyophilization was taken as 100 %. The wet precipitate was dissolved in 2 liters of deionized water and the insoluble material discarded. The salting out process was applied again and after the second precipitation, 68.6g
(24g dry weight) of wet precipitate was obtained. The recoveries of potency in the first and second precipitations were 55.8 % and 72.9 %, respectively.
Amberlite IRA-410 (Cl-type) Process
The MCR solution (455 ml), obtained by dissolving the second precipitate (described above) in deionized water, was fed to the Amberlite IRA-410 column. MCR was not adsorbed to the resin and 92.1 % of potency was recovered in the effluent. The effluent (656 ml) contained 21 g of dry material.
Concentration and Elimination of Low Molecular Contaminants by Ultrafiltration
By Dia-filter MC-6 using a GT-10 membrane (M.W. 10,000, Bio-engineering Co., Ltd.), the effluent (656 ml) obtained above was concentrated to 104 ml and ten volumes of deionized water were added. The filtration process was repeated yielding 100 ml of concentrate. Thus contaminants with molecular weights below 10,000 were eliminated and 2.3g of high molecular weight compounds remained in the concentrate. Recovery of potency was 58.1 %.
Decolorization of MCR by DEAE Sephadex A-25 (Cl-type)
Cl-type of DEAE Sephadex A-25 was used for decolorization of the MCR solution. DEAE Sephadex A-25 (5.0 g) was packed in a column. The concentrated solution (100 ml) obtained above was applied to the column followed by deionized water. A dark brown pigment was adsorbed to the column and 142.2 % of the MCR potency was found in the effluent (160 ml). The second gel filtration was carried out with the same column as previously described but the buffer solution was not used. The column was developed using deionized water only. The inhibiton zone is for Al. flavus.
Fraction number
The effluent contained 1.85 g dry material with a small quantity of yellowish pigment still remaining.
Gel Filtration of MCR on Sephadex G-50 (fine)
Chromatography was carried out using a Sephadex G-50 column (60 mm x 850 mm) treated with 0.1 M phosphate buffer at pH 7.0. The effluent (160 ml) obtained above was applied to this column. The column was eluted in order to obtain the fraction of about M.W. 10,000 representing the MCR. Low molecular contaminants had been eliminated already by ultrafiltration and consequently only high molecular contaminants appeared just before the MCR peak (Fig. 1) . The high molecular contaminants were removed in this step and the active fraction (244 ml) was collected. This step yielded material with a dry weight of 0.45 g representing 56 % recovery of the potency. The active fraction was concentrated to 100 ml by ultrafiltration simultaneously removing phosphate. During this last concentration, about 10 % of the potency and the dry weight was lost.
Chromatography on DEAE Sephadex A-25 (OH-type) The concentrate (100 ml) obtained above was charged to a DEAE Sephadex A-25 (OHtype, 10 g) column. MCR was not adsorbed to Cl-type of DEAE Sephadex but was adsorbed to OH-type of DEAE Sephadex. The adsorbed MCR was eluted with 0.1 M NaCl and a yellowish pigment remained on the resin. The eluate (415 ml) contained 0.15 g MCR representing a 28.6 % recovery of the potency. The pigment and other contaminants were removed completely in this step and the eluate was shown by polyacrylamide gel electrophoresis to contain pure MCR.
Rechromatography on Sephadex G-50 (fine) Gel filtration on Sephadex G-50 was carried out again to completely remove salt (Fig. 2) . XXIX NO. 4 The technique was applied to the eluate (415 ml) described above, using deionized water. The step yielded 0.11 g MCR (dry weight) in 175 ml effluent. Recovery of the potency was 83.3%.
Lyophilization of MCR
By lyophilization of the MCR solution, 98 mg of a white powder was obtained and stored in a desiccator in the freezer.
As described in Section II, the homogeneity of the lyophilized MCR powder was established by the described methods. Thus, the purification procedures were confirmed to remove all contaminants.
II. Characteristics of MCR Homogeneity of MCR
The purified MCR was confirmed to be homogeneous by gel filtration on Sephadex G-50, by analytical ultracentrifugation and by polyacrylamide gel electrophoresis. Gel filtration was carried out on a Sephadex G-50 column (60 mm X 850 mm) treated with 0.1 M phosphate buffer containing 0.1 M KC1 at pH 7.0. Sixteen-ml fractions were collected at a flow rate of 140 ml/hour.
A sharp, single peak of MCR was observed. No other peak representing a contaminant was found. MCR gave maximum absorption between 270 nm and 280 nm with a shoulder at 290 nm (Fig. 3) .
Analytical ultracentrifugation by the sedimentation velocity method was carried out on a solution containing 8 mg of MCR per ml at 72,000 rpm for 90 minutes. The sedimentation pattern of MCR showed a single peak. The sedimentation coefficient, S.,o.,, was 1.5.
Polyacrylamide gel was made in a glass tube according to the method Of ORSTEIN-DAVIS. NH.-terminal of MCR was shown to be alanine by dinitrophenylation11) and dancylationl2).
Determination of Isoelectric Point
The isoelectric point was determined by the electrofocusing procedure using LKB Ampholine 8101. The carrier ampholyte was in the range of pH 5.0 to 8.0. The MCR activity was detected in the fraction of pH 5.4. Thus, MCR was confirmed to be an acidic polypeptide having isoelectric point of pH 5.4 (Fig. 4) . Table 1 .
Estimation of Molecular Weight
The molecular weight of MCR was determined by gel filtration, amino acid analysis and analytical ultracentrifugation.
Gel filtration was carried out on a Sephadex G-50 column and Met. were not detected in MCR. The solution containing MCR and a test compound was adjusted to pH 5.07.5 and 2.0 ml of the resulting solution was lyophilized in a 10-m1 vial. The concentration of MCR was 2.5 mg/ml, in the solutions containing a saccharide. In other solutions, the concentration of MCR was 5.0 mg/ml. The vial was sealed and left at 65°C for 55 hours. By amino acid analysis and chemical modification using a sulfhydryl reagent such as p-chloromercuribenzoic acid, it was found that MCR had four cysteine molecules. Based on the amount of cysteine using the corrected value in Table 1 , the molecular weight was calculated to be 11,700.
Ultracentrifugation by the sedimentation equilibrium method was performed at 20,000 rpm for 16.5 hours. The molecular weight was shown to be 11,400.
Toxicity of MCR
The intraperitoneal LD50 was 5.1 mg/kg, and the intravenous LD50 was 6.4 mg/kg. Orally, 1.5 g/kg could be administered to mice without any sign of toxicity.
Stability of MCR
Various compounds were screened for their abilities to stabilize MCR. As shown in Table 2 , we found that sugars, amino acids and many other compounds were effective in stabilizing MCR, with disaccharides the most effective.
Among disaccharides, we selected maltose for study in detail.
As shown in Fig. 7 , the Fig. 7 is given in Fig. 8 .
The period for preserving at least 90% of the activity was calculated by the ARRHENIUS equation as follows: 37 months at 4°C, 17 months at 10°C, 3 months at 25°C and 31 days at 35°C.
Experimentally, the residual activity after 30 days at 35'C was confirmed to be 92.8 %. The MCR without maltose lost almost all of its activity during storage under these conditions.
Discussion
Extraction and purification of MCR presented a number of problems because of its sensitivity to temperature, light, ultraviolet and reductant. For best results the temperature of the culture broth and of broth filtrate should be kept below 10°C. In addition, careful, rapid filtration is required. Without these precautions, most of the activity is lost during filtration. Also in the case of the subsequent purification procedure, it should be handled carefully. In addition, exposure of the MCR solution or the powder to light should be avoided. Exacting chromatography by DEAE Sephadex A-25 is the most important step to obtain pure MCR; all remaining contaminants can be removed if this step is handled with precision. MCR thus purified was confirmed to be homogeneous with the characteristics agreeing fairly well with those in the original paper. MCR is an acidic polypeptide antibiotic having an isoelectric point of pH 5.4. It has the maximum UV-absorption between 270 nm and 280 nm and a shoulder at 290 nm. E,".'.1 is 11.6.
The molecular weight of MCR was shown to be about 12,000 by three different methods but the exact value must wait the detailed structural study.
As reported in the next paper, the NH.-terminal was confirmed to be alanine; two disulfide bonds are present in the molecule.
Up to this time the labile character of MCR has prevented biological study of this antibiotic in detail.
Fortunately 
